Key result
In silico electromechanical simulation accurately predicts CRT response in a patient with LBBB and HFrEF.
Why the study?
Some patients with heart failure and left ventricular dyssynchrony do not respond to cardiac resynchronization therapy, and methods to identify non-responders are unresolved.
Does patient-specific in silico CRT simulation predict CRT responsiveness in a patient with heart failure and LBBB?
Case Report (n=1)
No
Does patient-specific in silico CRT simulation predict CRT responsiveness in a patient with heart failure and LBBB?
A patient-specific in silico electromechanical heart model is a feasible technique to simulate and predict cardiac resynchronization therapy responsiveness in patients with heart failure and LBBB.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for patient-specific in silico CRT simulation; prospective validation needed before clinical use in HF with LBBB.
Cardiac resynchronization therapy (CRT) is an effective treatment option for patients with heart failure (HF) and left ventricular (LV) dyssynchrony. However, the problem of some patients not responding to CRT remains unresolved. This study aimed to propose a novel in silico method for CRT simulation. Three-dimensional heart geometry was constructed from computed tomography images. The finite element method was used to elucidate the electric wave propagation in the heart. The electric excitation and mechanical contraction were coupled with vascular hemodynamics by the lumped parameter model. The model parameters for three-dimensional (3D) heart and vascular mechanics were estimated by matching computed variables with measured physiological parameters. CRT effects were simulated in a patient with HF and left bundle branch block (LBBB). LV end-diastolic (LVEDV) and end-systolic volumes (LVESV), LV ejection fraction (LVEF), and CRT responsiveness measured from the in silico simulation model were compared with those from clinical observation. A CRT responder was defined as absolute increase in LVEF ≥ 5% or relative increase in LVEF ≥ 15%. A 68-year-old female with nonischemic HF and LBBB was retrospectively included. The in silico CRT simulation modeling revealed that changes in LVEDV, LVESV, and LVEF by CRT were from 174 to 173 mL, 116 to 104 mL, and 33 to 40%, respectively. Absolute and relative ΔLVEF were 7% and 18%, respectively, signifying a CRT responder. In clinical observation, echocardiography showed that changes in LVEDV, LVESV, and LVEF by CRT were from 162 to 119 mL, 114 to 69 mL, and 29 to 42%, respectively. Absolute and relative ΔLVESV were 13% and 31%, respectively, also signifying a CRT responder. CRT responsiveness from the in silico CRT simulation model was concordant with that in the clinical observation. This in silico CRT simulation method is a feasible technique to screen for CRT non-responders in patients with HF and LBBB.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2022) conducted a case report in Heart failure with left bundle branch block (n=1). In silico cardiac resynchronization therapy simulation vs. Clinical observation was evaluated on CRT responsiveness (absolute increase in LVEF ≥ 5% or relative increase ≥ 15%). An in silico cardiac resynchronization therapy simulation model successfully predicted CRT responsiveness in a patient with heart failure and left bundle branch block, concordant with clinical observations.
Synapse has enriched 10 related papers. Consider them for comparative context: